{
  "id": 17257509,
  "title": "Implant system could be a new way to treat type 2 diabetes",
  "url": "https://urgent.news/2026/10/30/implant-system-could-be-a-new-way-to-treat-type-2-diabetes",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-10-30T17:02:54.000Z",
  "source": {
    "name": "Futurity",
    "slug": "futurity",
    "url": "https://www.futurity.org/type-2-diabetes-implant-system-3350142/"
  },
  "original_language": "en",
  "account": "Researchers from ETH Zurich have developed a groundbreaking implantable system that offers a potential new approach to treating type 2 diabetes. This innovative device aims to address the chronic energy surplus often associated with the condition, which is becoming increasingly prevalent worldwide. Unlike insulin injections that merely help cells absorb glucose, the new system directly lowers blood glucose levels using an electrically powered catalyst.\n\nThe catalyst is made entirely from inorganic materials, such as graphite felt, gold nanoclusters, and platinum particles, eliminating the need for biological components. This design offers several advantages, including superior biocompatibility, easier manufacturing, and fewer regulatory hurdles compared to previous approaches that relied on genetic networks or biological elements. The system is housed in a 3D-printed casing and features an electronic control unit that operates wirelessly at a frequency of 13.56 MHz, designated for industrial, scientific, and medical applications.\n\nA key feature of the implant is its ability to convert excess glucose into gluconate, which can then be excreted through urine rather than being metabolized and stored as fat. The catalyst's activity is regulated through a closed-loop system, with a standard glucose sensor monitoring tissue glucose levels. When blood sugar levels rise excessively after a meal, the sensor sends a Bluetooth signal to a smartphone or smartwatch, which in turn activates the catalyst to convert the glucose. Once glucose levels return to a desired range, the device automatically switches off, preventing dangerously low blood sugar levels.\n\nLaboratory tests confirmed the system's effectiveness in a five-liter glucose-containing nutrient solution and demonstrated its ability to regulate blood sugar in diabetic mice over a six-week period. Notably, the mice experienced weight loss, and the device was well-tolerated, with no signs of tissue damage from electrical or thermal effects.\n\nWhile the researchers have not yet tested the device on humans, they envision this system as a paradigm shift in diabetes treatment, moving away from conventional drug-based approaches towards scalable, electronically controlled solutions that can integrate with digital environments like the Internet of Things. The team aims to further develop the technology into a medical device, taking advantage of existing commercially available components for external control and wireless power transmission.",
  "summary": "\"We are now showing that we can take control of glucose directly, using electronics rather than drugs.\"",
  "key_points": [
    "ETH Zurich researchers develop implantable system for type 2 diabetes treatment",
    "Catalyst converts excess glucose to gluconate for excretion via urine",
    "Closed-loop system regulates glucose using wireless glucose sensor"
  ],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}